How fortunate for Imugene that our Aze-Cel CAR-T therapy is Allogeneic and not Autologous!!!!
While the FDA continues to scrutinize our competitors increasingly unsafe CAR-T products - now forcing them to label their boxes with warnings of potential cancer-causing side effects, our Azer-Cel therapy continues to progress at light speed and with fantastic results.
Azer-Cel CAR-T Therapy: "Best in Class and First in Class" as Leslie likes to remind the market.
Media Thread, page-11491
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.004(6.25%) |
Mkt cap ! $439.1M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.5¢ | 5.9¢ | $2.751M | 44.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1171830 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1188733 | 16 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
-0.004 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 6.4¢ | 6.5¢ | 5.9¢ | 22305109 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| IMU (ASX) Chart |